文献速递心肺康复

虚拟现实辅助低资源环境维持期心脏康复的随机交叉试验:对依从性、动机与参与度的影响

A Randomized, Controlled, Crossover Trial of Virtual Reality in Maintenance Cardiovascular Rehabilitation in a Low-Resource Setting: Impact on Adherence, Motivation, and Engagement.
PubMed 文献 · Phys Ther · 2021-01-01

结果显示VR使12周依从性显著提高(82.80% vs 基线72.87%),但撤除后依从性下降至65.48%;同时VR期间动机和吸收度显著降低。

要点

  • 每周1次VR替代常规训练可提高12周心脏康复依从性约8%(3/36次),但撤除VR后效应消失。
  • VR加入常规康复期间患者动机和吸收度反而显著下降,与假设相反。
  • 临床设计VR方案时需考虑其对动机和参与度的潜在负面影响。

核心结论

  • 在维持期心脏康复中每周加入1次VR可显著提高项目依从性,但撤除VR后依从性回落。
  • 与假设相反,VR与常规训练交替进行反而降低了患者动机和吸收度。

研究设计与样本

  • 随机、1:1隐蔽分配、单盲、两平行臂交叉试验,在巴西单一不限时长心脏康复项目中实施。
  • 常规康复为每周3次监督下运动训练;VR组在最初12周每周1次VR替代常规训练,后12周撤除VR。
  • 主要结局为项目依从性(12周内每周3次的完成百分比)、动机(BREQ-3)和参与度(改编版用户参与量表,含活力、奉献、吸收分量表)。

主要发现

  • VR组12周依从性从基线72.87%显著升至82.80%,撤除VR后24周降至65.48%;常规组无随时间变化。
  • 12周时VR组依从性显著高于常规组(73.51%)。
  • VR组动机从基线4.32(SD=0.37)显著降至12周4.02(SD=0.76),12至24周又显著升至4.37(SD=0.36)。
  • VR组12周吸收度显著低于基线(6.79 [SD=0.37] vs 6.20 [SD=1.01])。

临床怎么用

  • 在低资源维持期心脏康复中,可考虑每周1次VR运动游戏替代常规训练以提高短期依从性。
  • 需监测VR介入对动机和吸收度的负面影响,避免长期交替安排导致参与度下降。
  • 撤除VR后应加强行为支持以维持依从性。

局限性

  • 参与者基线动机和参与度已较高,可能限制动机提升空间。
  • VR仅每周1次且12周后撤除,无法评估其他剂量或长期效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to investigate the effects of adding virtual reality (VR) to maintenance cardiac rehabilitation (CR); it was hypothesized VR would increase adherence, motivation, and engagement. METHODS: This study was a randomized, 1:1 concealed-allocation, single-blinded, 2 parallel-arm, crossover trial. Blinded assessments were undertaken at baseline (midprogram), 12 weeks, and 24 weeks after baseline. The setting was a single CR program of unlimited duration in Brazil. Participants were patients with cardiovascular diseases or risk factors who had been in the program for 3 months or longer. The CR program consisted of 3 supervised exercise sessions per week. In the VR arm, participants had 1 VR session of the 3 per week during the initial 12 weeks of the trial; this was withdrawn the subsequent 12 weeks. Measures were program adherence (% of 3 sessions/week over 12 weeks, ascertained in all participants), motivation (Behavioral Regulation in Exercise Questionnaire 3), and engagement (User Engagement Scale, adapted; vigor, dedication, and absorption subscales); all 3 were primary outcomes. RESULTS: Sixty-one (83.6%) patients were randomly assigned (n = 30 to CR + VR); 54 (88.5%) were retained at 12 and 24 weeks. At baseline, participants had been in CR on average 7 years and had high engagement and motivation. CR + VR resulted in a significant increase in adherence at 12 weeks (baseline = 72.87%; 12 weeks = 82.80%), with significant reductions at 24 weeks when VR was withdrawn (65.48%); in the usual CR care arm, there were no changes over time. There was a significant effect for arm, with significantly higher adherence in the CR + VR arm than usual CR at 12 weeks (73.51%). Motivation decreased significantly from baseline to 12 weeks (4.32 [SD = 0.37] vs 4.02 [SD = 0.76]) and significantly increased from 12 to 24 weeks in the CR + VR arm (4.37 [SD = 0.36]). Absorption was significantly lower at 12 weeks in the CR + VR arm (6.79 [SD = 0.37] vs 6.20 [SD = 1.01]). CONCLUSION: Although VR increased program adherence, interspersing it with usual CR sessions actually decreased patient motivation and absorption. IMPACT: Supplementing a maintenance CR program with VR using "exergames" resulted in significantly greater adherence (8% increase or 3 of 36 sessions), and this was quite a robust effect given it was extinguished with the removal of VR. However, contrary to the hypotheses, offering 1 session of VR per week and 2 of usual CR exercise was related to lower motivation and absorption, which has implications for how clinicians design programs for this patient population.

来源:Phys Ther,查看原文。版权归原作者所有。

引用

  1. da Cruz MMA, Ricci-Vitor AL, Borges GLB, et al. A Randomized, Controlled, Crossover Trial of Virtual Reality in Maintenance Cardiovascular Rehabilitation in a Low-Resource Setting: Impact on Adherence, Motivation, and Engagement. Phys Ther. 2021. PMID: 33625515. doi:10.1093/ptj/pzab071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。